Document:

Registration Rights Agreement

 Exhibit 10.2 
 FORM OF 
 REGISTRATION RIGHTS AGREEMENT 
 THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made
and entered into as of this         day of July, 2009 by and among Arrowhead Research Corporation, a Delaware corporation (the “Company”) and the purchasers of the Company’s Units
(as defined below) listed on Exhibit A hereto, as may be amended from time to time (the “Investors”). 
 RECITALS 
 WHEREAS, the Investors are purchasing units (the
“Units”), each consisting of one (1) share of the Company’s common stock, par value $0.001 per share (the “Common Stock” and such shares of Common Stock under the Units, the
“Shares”) and one (1) warrant (the “Warrants”) exercisable for shares of Common Stock (the “Warrant Shares”) or, in certain circumstances, a fractional share of the
Company’s Series A Preferred Stock, pursuant to a Subscription Agreement by and between the Company and each Investor dated as of the date hereof (collectively, the “Purchase Agreements”); 
 WHEREAS, in connection with the consummation of the transactions under the Purchase Agreements, the Company and the Investors have
agreed to the provisions as set forth below. 
 NOW, THEREFORE, in consideration of these premises and
intending to be legally bound, the parties hereto agree as follows: 
 1. Certain Definitions. As used in this Agreement, the
following terms shall have the following respective meanings: 
 “Affiliate” means, with respect to any specified Person, a
Person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the specified Person, where “control” (including the terms “controlling,” “controlled
by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by
contract, or otherwise; provided, however, that when used with respect to the Company, “Affiliate” shall not include any Investor or Affiliate thereof. 
 “Closing Date” means the date of the closing of the purchase and sale of Units under the Purchase Agreements. 
 “Commission” means the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, or any
similar federal rule or statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 
 “Registrable Securities” means any (i) Shares purchased by the Investors pursuant to the Purchase Agreements, (ii) Warrant Shares issued or issuable upon exercise of those certain Warrants issued pursuant to the
Purchase Agreements, and (iii) Common Stock issued or issuable in respect of the foregoing upon any stock split, stock dividend, recapitalization or 

 
similar event; provided, however, that such securities shall only be treated as Registrable Securities if and so long as they have not been sold
pursuant to a registration or in accordance with Rule 144. 
 The terms “register,” “registered” and
“registration” refer to a registration effected by preparing and filing a Registration Statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such Registration Statement. 

“Registration Expenses” shall mean all expenses, except as otherwise stated below, incurred by the Company in complying with
Section 2(a) and 2(c) hereof, including without limitation, all registration, qualification and filing fees, printing expenses, escrow fees, fees and disbursements of counsel for the Company, blue sky fees and expenses, the expense of any
special audits incident to or required by any such registration (but excluding the compensation of regular employees of the Company which shall be paid in any event by the Company and excluding any underwriters discounts or commissions which may be
applicable). Registration Expenses shall also include the reasonable fees and disbursements for one special counsel to the selling Investors holding Registrable Securities reasonably acceptable to the Company, but shall not include any other fees or
expenses of the Investors. 
 “Registration Statements” means any one or more registration statements of the Company filed
under the Securities Act that covers the resale of any of the Registrable Securities pursuant to the provisions of this Agreement (including without limitation the Initial Registration Statement, the Warrant Registration Statement, the New
Registration Statement and any Remainder Registration Statements), amendments and supplements to such Registration Statements, including post-effective amendments, all exhibits and all material incorporated by reference or deemed to be incorporated
by reference in such Registration Statements. 
 “Rule 144” and “Rule 145” shall mean Rules 144 and 145,
respectively, promulgated under the Securities Act, as such rules may be amended from time to time, or any similar federal rules thereunder, all as the same shall be in effect at the time. 
 “Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, or any similar
federal rule or statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 
 2.
Registration Rights. 
 (a) Company Registration of Shares and Warrant Shares. Subject to the receipt of
necessary information from the Investors after prompt request from the Company to the Investor to provide such information, the Company shall: (i) use best efforts to cause a Registration Statement on Form S-3 (or other appropriate form)
covering the resale of all of the Shares and, at the discretion of the Company, the Warrant Shares, not already covered by an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415 or, if
Rule 415 is not available for offers and sales of the Registrable Securities, by such other means of distribution of Registrable Securities as the Investors may reasonably specify (the “Initial Registration Statement”), to be
filed with the Commission within 30 days after the Closing Date, (ii) if the Warrant Shares are not covered under the Initial 

  

 2 

 
Registration Statement, use commercially reasonable efforts to either (A) cause a Registration Statement on Form S-3 (or other appropriate form)
covering the resale of all of the Warrant Shares not already covered by an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415 or, if Rule 415 is not available for offers and sales of
the Registrable Securities, by such other means of distribution of Registrable Securities as the Investors may reasonably specify to be filed with the Commission (the “Warrant Registration Statement”) or (B) file a
post-effective amendment to the Initial Registration Statement or other Registration Statement covering the Warrant Shares, in either case, promptly following stockholder approval, if necessary, of the requisite increase in the Company’s Common
Stock to cover the exercise of the Warrant Shares. 
 Following the Registration Statement being declared effective by the SEC, the Company
shall file with the SEC in accordance with Rule 424 under the Securities Act the final prospectus contained in such Registration Statement. 
 Notwithstanding the registration obligations set forth in this Section 2(a), in the event the Commission informs the Company that all of the Registrable Securities, Shares and/or Warrant Shares, cannot, as a result of the application
of Rule 415, be registered for resale as a secondary offering on a single Registration Statement, the Company agrees to promptly (i) inform each of the Investors thereof and use its commercially reasonable efforts to file amendments to the
Initial Registration Statement as required by the Commission and/or (ii) withdraw the Initial Registration Statement and/or Warrant Share Registration Statement and file a new Registration Statement (a “New Registration
Statement”), in either case covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering; provided, however, that prior to filing such amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable efforts to advocate with the Commission for the registration of all of the Registrable
Securities in accordance with any publicly-available written or oral guidance, comment, requirements or requests of the Commission staff and the Securities Act (collectively, the “SEC Guidance”), including without limitation,
the Manual of Publicly Available Telephone Interpretations D.29. Notwithstanding any other provision of this Agreement, if any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted to be registered on a particular
Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater number of Registrable Securities), unless otherwise directed in
writing by an Investor as to its Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will first be reduced by Registrable Securities not acquired pursuant to the Purchase Agreements (whether
pursuant to registration rights or otherwise), second by Registrable Securities represented by holders of Warrant Shares (applied, in the case that some Warrant Shares may be registered, to the Investors on a pro rata basis based on the total number
of unregistered Warrant Shares held by such Investors) and third by Registrable Securities represented by Shares (applied, in the case that some Shares may be registered, to the Investors on a pro rata basis based on the total number of unregistered
Shares held by such Investors, subject to a determination by the Commission that certain Investors must be reduced first based on the number of Shares held by such Investors). In the event the Company amends the Initial Registration Statement or the
Warrant Registration Statement or files a New Registration Statement, as the case may be, under clauses (i) or (ii) above, the 

  

 3 

 
Company will use its commercially reasonable efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the
Company or to registrants of securities in general, one or more Registration Statements on Form S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration
Statement or Warrant Registration Statement, both as amended, or the New Registration Statement (the “Remainder Registration Statements”). 
 Subject to this Section 2(a), the Company will include in such registration (and any related qualifications including compliance with blue sky laws), and in any underwriting involved therein, all Registrable
Securities specified by any Investor in a written request or requests to the Company, made within ten days after the date of written notice of such registration from the Company to the Investors. Each Investor agrees that it shall not be entitled to
be named as a selling securityholder in any Registration Statement or use a prospectus for offers and resales of Registrable Securities at any time, unless such Investor has returned to the Company a completed and signed Investor Suitability
Questionnaire and a response to any requests for further information by the Company. 
 (b) Effectiveness of
Registration. The Company shall use commercially reasonable efforts to cause any Registration Statement to be declared effective by the Commission no later than ninety (90) days after filing or one hundred twenty (120) days in the
event of a review by the staff of the Commission, and (iii) use best efforts to keep such Registration Statement continuously effective until the earlier of (A) one (1) year from the date of the closing of the Purchase Agreements and
(B) the date on which any Registrable Securities held by the Investors may be sold in their entirety in a single transaction pursuant to Rule 144. 
 (c) Expenses of Registration. All Registration Expenses incurred in connection with the registration described in Section 2 shall be borne by the Company. All other registration expenses, if
any, shall be borne by the Investors pro rata on the basis of the number of shares so registered or proposed to be so registered. 
 (d) Registration Procedures. The Company will keep each Investor advised in writing as to the initiation of the registration described in Section 2(a) and as to the completion thereof. The Company will: 

(i) Registration Statements. Prepare and file with the Commission the Registration Statements with respect to such Registrable
Securities and cause such Registration Statements to become effective and remain effective, in each case in accordance with the timeframes provided in Sections 2(a)-(b). 
 (ii) Amendments and Supplements. Prepare and file with the Commission such amendments and supplements to such Registration Statements and the prospectus used in connection with such Registration
Statements as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such Registration Statements for the period set forth in Section 2(b) above. 
 (iii) Prospectus. Furnish to the Investors such number of copies of the Registration Statements, any amendments thereto, any documents
incorporated by reference 

  

 4 

 
therein, a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may
reasonably request in order to facilitate the disposition of Registrable Securities owned by them, which disposition by the Investors shall be in compliance with the Registration Statement and applicable federal and state securities laws; provided
that the Company shall have no obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR system. 
 (iv) Qualification. Use commercially reasonable efforts to register and qualify the securities covered by such Registration Statements under such other securities or blue sky laws of such jurisdictions as shall be reasonably
requested by the Investors; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, unless
the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act. 
 (v)
Underwriting Obligations. In the event of any underwritten public offering of Registrable Securities, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter(s) of
such offering. Each Investor participating in such underwriting shall also enter into and perform its obligations under such an underwriting agreement. The Company shall, if requested by the managing underwriter or underwriters, if any, counsel to
Investors, or any holder of Registrable Securities included in such offering, promptly incorporate in a prospectus supplement or post-effective amendment such information as such managing underwriter or underwriters, counsel to Investors or any
holder of Registrable Securities reasonably requests to be included therein, and which is reasonably related to the offering of such Registrable Securities, including, without limitation, with respect to the Registrable Securities being sold by such
holder to such underwriter or underwriters, the purchase price being paid therefor by such underwriter or underwriters and any other terms of an underwritten offering of the Registrable Securities to be sold in such offering, and the Company shall
promptly make all required filings of such prospectus supplement or post-effective amendment. 
 (vi) Notice. Immediately
notify each Investor holding Registrable Securities covered by a Registration Statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the
prospectus included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in
light of the circumstances then existing (a “Suspension Notice”); provided, however, that (i) the Company shall not give more than two Suspension Notices during any period of twelve consecutive months, (ii) any such
Suspension Notice shall not be given within 120 days of the end of the Suspension Notice period under the prior Suspension Notice and (iii) in no event shall the period from the date on which any holder of Registrable Securities receives a
Suspension Notice until the date on which such holder receives copies of the supplemented or amended prospectus or is advised in writing by the Company that the use of the prospectus may be resumed exceed for all Suspension Notices in the aggregate,
60 days in any 365 day period. The Company will use commercially reasonable efforts to promptly amend or supplement such prospectus in order to cause such prospectus not to include any untrue statement of a material fact or omit to state a material
fact required to be 

  

 5 

 
stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing. 
 (vii) Listing. Cause all such Registrable Securities registered pursuant hereto to be listed on each securities exchange or automated
quotation system on which similar securities issued by the Company are then listed. 
 (viii) Stop Orders. Use commercially
reasonable efforts to prevent the issuance of any order suspending the effectiveness of a Registration Statement relating to Registrable Securities, and if one is issued, use commercially reasonable efforts to obtain the withdrawal of any order
suspending the effectiveness of such Registration Statement at the earliest possible moment. 
 (ix) Company Records. Upon
reasonable notice, make available to each Investor, any underwriter participating in any disposition pursuant to a Registration Statement relating to Registrable Securities, and any attorney, accountant or other agent or representative retained by
any such Investor or underwriter (collectively, the “Inspectors”), all financial and other records, pertinent corporate documents and properties of the Company (collectively, the “Records”) reasonably
necessary to enable them to exercise their due diligence responsibility, and cause the Company’s officers, directors and employees to supply all information requested by any such Inspector in connection with such Registration Statement,
provided that each such Investor and Inspector has entered into a customary confidentiality agreement with respect to such Records. 
 (x) NASD Matters. Cooperate with each Investor and each underwriter participating in the disposition of Registrable Securities and their respective counsel in connection with any filings required to be made with the National
Association of Securities Dealers, Inc. (“NASD”), including, if appropriate, the pre-filing of a prospectus as part of a Registration Statement in advance of an underwritten offering. 
 (e) Indemnification. 
 (i) Company Indemnification. The Company will indemnify each Investor who holds Registrable Securities (if Registrable Securities held by such Investor are included in the securities as to which such registration is being
effected), each of its officers and directors and partners, and each person controlling such Investor within the meaning of Section 15 of the Securities Act, with respect to which registration has been effected pursuant to this Agreement,
against all expenses, claims, losses, damages or liabilities (or actions in respect thereof), including any of the foregoing incurred in settlement of any litigation, commenced or threatened, arising out of or based on any untrue statement (or
alleged untrue statement) of a material fact contained in any Registration Statement, prospectus, offering circular or other document, or any amendment or supplement thereto, incident to any such registration, or based on any omission (or alleged
omission) to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or any violation by the Company of the Securities Act, the
Exchange Act, state securities laws or any rule or regulation promulgated under such laws applicable to the Company in connection with any such registration, and the Company will reimburse each such 

  

 6 

 
Investor, each of its officers and directors, and each person controlling such Investor, for any legal and any other expenses reasonably incurred, as such
expenses are incurred, in connection with investigating, preparing or defending any such claim, loss, damage, liability or action, provided that the Company will not be liable in any such case to the extent that any such claim, loss, damage,
liability or expense arises out of or is based on (A) any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Company by an instrument duly
executed by such Investor or controlling person, and stated to be specifically for use therein, (B) the use by Investor of an outdated or defective prospectus after the Company has notified such Investor in writing that the prospectus is
outdated or defective or (C) Investor’s (or any other indemnified person’s) failure to send or give a copy of the prospectus or supplement (as then amended or supplemented), if required, pursuant to Rule 172 under the Securities Act
(or any successor rule) to the Persons asserting an untrue statement or alleged untrue statement or alleged untrue statement or omission or alleged omission at or prior to the written confirmation of the sale of Registrable Securities to such person
if such statement or omission was corrected in such prospectus or supplement; provided, further, that the indemnity agreement contained in this subsection 2(e)(i) shall not apply to amounts paid in settlement of any such loss, claim, damage,
liability or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld). 
 (ii) Investor Indemnification. Each Investor holding Registrable Securities will, if Registrable Securities held by such Investor are included in the securities as to which such registration is being effected, severally and
not jointly, indemnify the Company, each of its directors and officers, other holders of the Company’s securities covered by such Registration Statement, each person who controls the Company within the meaning of Section 15 of the
Securities Act, and each such holder, each of its officers and directors and each person controlling such holder within the meaning of Section 15 of the Securities Act, against all claims, losses, damages and liabilities (or actions in respect
thereof) arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any such Registration Statement, prospectus, offering circular or other document, or any omission (or alleged omission) to state
therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or any violation by such holder of the Securities Act, the Exchange Act, state securities laws or any rule or regulation promulgated
under such laws applicable to such Investor, and will reimburse the Company, each other holder, and directors, officers, persons, underwriters or control persons of the Company and the other holders for any legal or any other expenses reasonably
incurred, as such expenses are incurred, in connection with investigating or defending any such claim, loss, damage, liability or action, but in the case of the Company or such other holders or their officers, directors or controlling persons, only
to the extent that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such Registration Statement, prospectus, offering circular or other document in reliance upon and in conformity with written
information furnished to the Company by an instrument duly executed by such Investor and stated to be specifically for use therein; provided, further, that the indemnity agreement contained in this Subsection 2(e)(ii) shall not apply to amounts paid
in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of such indemnifying Investor (which consent shall not be unreasonably withheld or delayed). The liability of any Investor for
indemnification under this 

  

 7 

 
Section 2(e) in its capacity as a seller of Registrable Securities shall not exceed the amount of net proceeds to such Investor of the securities sold
in any such registration. 
 (iii) Notice and Procedure. Each party entitled to indemnification under this Section 2(e)
(the “Indemnified Party”) shall give written notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim
as to which indemnity may be sought, and shall permit the Indemnifying Party to assume the defense of any such claim or any litigation resulting therefrom, provided that counsel for the Indemnifying Party, who shall conduct the defense of such claim
or litigation, shall be approved by the Indemnified Party (whose approval shall not unreasonably be withheld), and the Indemnified Party may participate in such defense at such party’s expense, and provided further that the failure of any
Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Agreement unless the failure to give such notice is materially prejudicial to an Indemnifying Party’s ability to defend
such action and provided further, that the Indemnifying Party shall not assume the defense for matters as to which there is a conflict of interest or there are separate and different defenses. No Indemnifying Party, in the defense of any such claim
or litigation, shall, except with the consent of each Indemnified Party (whose consent shall not be unreasonably withheld), consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the
giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation. 
 (iv) Contribution. If the indemnification provided for in this Section 2(e) is held by a court of competent jurisdiction to be unavailable to an Indemnified Party with respect to any losses, claims, damages or liabilities
referred to herein, the Indemnifying Party, in lieu of indemnifying such Indemnified Party thereunder, shall to the extent permitted by applicable law contribute to the amount paid or payable by such Indemnified Party as a result of such loss,
claim, damage or liability in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with the untrue statement or omission that resulted in
such loss, claim, damage or liability, as well as any other relevant equitable considerations. The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by a court of law by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access
to information and opportunity to correct or prevent such statement or omission; provided, that in no event shall any contribution by an Investor hereunder exceed the proceeds from the offering received by such Investor. The amount paid or
payable by a party as a result of any loss, claim, damage or liability shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in
connection with any proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section 2(e) was available to such party in accordance with its terms. 
 (v) Survival. The obligations of the Company and the Investors under this Section 2(e) shall survive completion of any offering of
Registrable Securities in a Registration Statement and the termination of this Agreement. The indemnity and contribution 

  

 8 

 
agreements contained in this Section 2(e) are in addition to any liability that the Indemnifying Parties may have to the Indemnified Parties and are not
in diminution or limitation of the indemnification provisions under the Purchase Agreements. 
 (f) Information by
Investor. Any Investor holding Registrable Securities included in any Registration Statement shall furnish to the Company such information regarding such Investor, the Registrable Securities held by such Investor and the distribution
proposed by such Investor as the Company may request in writing and as shall be required in connection with any registration referred to in this Agreement. 
 (g) Confidentiality. Each Investor agrees that any and all material, non-public information received in connection with this Agreement shall remain confidential to each Investor until such
information otherwise becomes public, unless disclosure by an Investor is required by law; and provided, further, that notwithstanding each Investor’s agreement to keep such information confidential, each such Investor makes no acknowledgement
that any such information is material, non-public information. 
 (h) Compliance. Each Investor covenants and agrees
that it will (i) comply with the prospectus delivery requirements of the Securities Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to the Registration Statement
and shall sell the Registrable Securities only in accordance with a method of distribution described in the Registration Statement and will not transfer the Registrable Securities without registration under the Securities Act or applicable state
securities laws or an exemption therefrom and (ii) shall not use an outdated or defective prospectus after the Company has notified such Investor in writing that the prospectus is outdated or defective. 
 3. Amendment. Except as otherwise provided herein, any provision of this Agreement may be amended or the observance thereof may be
waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and Investors holding a majority of the then-outstanding Registrable Securities. Any amendment or waiver
effected in accordance with this Section 3 shall be binding upon each Investor, any transferee thereof and the Company. 
 4.
Governing Law. This Agreement shall be governed in all respects by the internal laws of the State of Delaware without regard to conflict of laws provisions. 
 5. Entire Agreement. This Agreement constitutes the full and entire understanding and Agreement among the parties regarding the matters set forth herein. Except as otherwise expressly provided
herein, the provisions hereof shall inure to the benefit of, and be binding upon the successors, assigns, heirs, executors and administrators of the parties hereto. 
 6. Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement
shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this
Agreement. 
  

 9 

 7. Successors and Assigns. Except as otherwise expressly provided herein, the
provisions hereof shall inure to the benefit of, and be binding upon, the Company’s and each Investor’s successors, assigns and transferees, including, without limitation and without the need for an express assignment, subsequent holders
of Registrable Securities. If any assignee or transferee of any Investor shall acquire Registrable Securities in any manner, whether by operation of law or otherwise, such Registrable Securities shall be held subject to all of the terms of this
Agreement, and by taking and holding such Registrable Securities such person shall be deemed to have agreed to be bound by and to perform all of the terms and provisions of this Agreement and such person shall be entitled to receive the benefits
hereof. 
 8. Notices. All notices and other communications required or permitted hereunder shall be in writing and
shall be mailed by registered or certified mail, postage prepaid, or otherwise delivered by facsimile transmission, by hand or by messenger, addressed: 
 (a) Investor. If to an Investor, at such Investor’s address as set forth in the Purchase Agreement, or at such other address as such Investor shall have furnished to the Company. 

(b) Company. If to the Company, to: 
 Arrowhead Research Corporation 
 201 South Lake Avenue, Suite 703 
 Pasadena, California 91101 
 Attention:
President; 
 Facsimile number 626-792-5554 
 or at such other address as the Company shall have furnished to the Investors, with a copy (which shall not constitute notice) to
Goodwin Procter LLP, Three Embarcadero Center, 24th Floor, Attn.: Ryan Murr.

 Each such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given when delivered if delivered
personally, if sent by facsimile, the first business day after the date of confirmation that the facsimile has been successfully transmitted to the facsimile number for the party notified, or, if sent by mail, at the earlier of its receipt or 72
hours after the same has been deposited in a regularly maintained receptacle for the deposit of the United States mail, addressed and mailed as aforesaid. 
 9. Counterparts. This Agreement may be executed by facsimile, in any number of counterparts, each of which shall be an original and all of which together shall constitute one instrument.

 10. Specific Performance. The parties hereto specifically acknowledge that monetary damages are not an adequate
remedy for violations of this Agreement, and that any party hereto may, in its sole discretion, apply to a court of competent jurisdiction for specific performance or injunctive or such other relief as such court may deem just and proper in order to
enforce this Agreement or prevent any violation hereof and, to the extent permitted by applicable 

  

 10 

 
law and to the extent the party seeking such relief would be entitled to the merits to obtain such relief, each party waives any objection to the imposition
of such relief. 
 11. Designation of Forum and Consent to Jurisdiction. The parties hereto (i) designate the
courts of the State of Delaware as the forum where all matters pertaining to this Agreement may be adjudicated, and (ii) by the foregoing designation, consent to the exclusive jurisdiction and venue of such courts for the purpose of
adjudicating all matters pertaining to this Agreement. 
 12. Stock Split. All references to numbers of shares in this
Agreement shall be appropriately adjusted to reflect any stock dividend, split, combination or other recapitalization of shares by the Company occurring after the date of this Agreement. 
 13. Independent Nature of Investors’ Obligations and Rights. The obligations of each Investor hereunder are several and not
joint with the obligations of any other Investor hereunder, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor hereunder. The decision of each Investor to purchase Units pursuant to the
Purchase Agreements has been made independently of any other Investor. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Investor pursuant hereto or thereto, shall be deemed to
constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert with respect to such obligations or the transactions contemplated by
this Agreement. Each Investor shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Investor to be joined as an additional party in any
proceeding for such purpose. The Company acknowledges that each of the Investors has been provided with the same Registration Rights Agreement for the purpose of closing a transaction with multiple Investors and not because it was required to do so
by any Investor. 
 [Signature Page to follow] 
  

 11 

 IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement as of the date
first set forth above. 
  

			
	 ARROWHEAD RESEARCH CORPORATION

		
	By:	 	  

	Name:	 	  

	Title:	 	  

 IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement as of the date
first set forth above. 
  

			
	 INVESTOR

	
	  

	Name of Investor:
		
	By:	 	  

	Name:	 	  

	Title:Form of Common Stock Certificate

 Exhibit 4.4 
  

			
	COMMON STOCK	 	COMMON STOCK
		
	NUMBER	 	SHARES
		
	TH             	 	
		
	PAR VALUE $0.05	 	SEE REVERSE FOR CERTAIN DEFINITIONS
		
	 THIS CERTIFICATE IS TRANSFERABLE IN JERSEY CITY, NJ,
 NEW YORK, NY AND PITTSBURGH, PA
	 	 CUSIP 88033G 10 0

 

 
 TENET HEALTHCARE CORPORATION 
 INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA 
 This Certifies that 
 

 
 is the record holder of 
 FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK OF 
 Tenet Healthcare Corporation transferable on the books of the
Corporation in person or by duly authorized Attorney upon surrender of this Certificate properly endorsed. This Certificate is not valid until countersigned by the Transfer Agent and registered by the Registrar. 
 Witness the facsimile seal of the Corporation and the facsimile signatures of its duly authorized officers. 
 Dated: 
  

					
	 /s/ Gary Ruff
	    		    	 /s/ Trevor Fetter

	GENERAL COUNSEL AND CORPORATE SECRETARY	    	[Seal]	    	PRESIDENT AND CHIEF EXECUTIVE OFFICER
		
	COUNTERSIGNED AND REGISTERED:	    	
		
	THE BANK OF NEW YORK MELLON	    	
	TRANSFER AGENT AND REGISTRAR	    	

					
			
	BY	 	  
	    	
		 	AUTHORIZED SIGNATURE	    	

 A copy of any statement of designations, preferences and relative, participating, optional or other
special rights of any classes of stock or series thereof, and any qualifications, limitations or restrictions of such rights, will be furnished to any stock holder of the corporation upon request and without charge by writing to the principal
office of Tenet Healthcare Corporation. 
 The following abbreviations, when used in the inscription on the face of this certificate, shall
be construed as though they were written out in full according to applicable laws or regulations: 
  

													
	TEN COM	 	—	 	as tenants in common	 		 	UNIF GIFT MIN ACT	 	—
	 	 . . . . . . . . Custodian . . . . . . . .
 (Cust)                        (Minor)
 under Uniform Gifts to Minors
 Act . . . . . . . . . . . . . . . . . . . . . . . .
                    (State)

	TEN ENT	 	—	 	as tenants by the entireties	 	 	 	 
	JT TEN	 	—	 	 as joint tenants with right of
 survivorship and not as
tenants
 in common
	 	 	 	 
		 		 		 	 	UNIF TRF MIN ACT	 	—
	 	 . . . . . . . Custodian (until age . . .)
 (Cust)
 . . . . . . . under Uniform Transfers
 (Minor)

 to Minors Act . . . . . . . . . . . . . . . . .
                             (State)

 Additional abbreviations may also be used though not in the above list. 
 FOR VALUE RECEIVED,                     
hereby sell, assign and transfer unto 
  

			
	PLEASE INSERT SOCIAL SECURITY OR OTHER	  	
	 IDENTIFYING NUMBER OF ASSIGNEE
	  	

  

			
	 	  	
	  	

  

			
	  

	(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE)
	
	  

	
	  

		
	  
	 	Shares

							
	of the common stock represented by the within Certificate, and do hereby irrevocably constitute and appoint	 	  
	 		 	

					
	  
	 	Attorney	 	
	to transfer the said stock on the books of the within named Corporation with full power of substitution in the premises.	 	

  

			
	Dated	 	 

  

			
	X	 	 
		
	X	 	 
		 	THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME(S) AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER.

 
  

			
	Signature(s) Guaranteed
		
	By	 	 
	THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED
SIGNATURE GUARANTEE MEDALLION PROGRAM). PURSUANT TO S.E.C. RULE 17Ad-15.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]